Shanghai Model Organisms Center Inc. Stock Analysis 688265.SS

Shanghai Model Organisms Center, Inc. provides life science research and drug discovery services for cancer immunotherapy. The company is headquartered in Shanghai, Shanghai and currently employs 848 full-time employees. The company went IPO on 2021-12-28. The firm's businesses include genetically modified animal model, model breeding, feeding service, efficacy evaluation and phenotypic analysis, other model biotechnology services, model purchase and sales business and other businesses. The genetically modified animal model products are divided into customized models and standardized models, mainly including genetically modified mouse models, genetically modified rat models, genetically modified nematode models and genetically modified zebrafish models. The model breeding business refers to the use of genetically modified animal models developed and produced by the issuer or existing genetically modified animal models provided by customers through natural breeding or assisted reproductive breeding.